WAC and invasive breast carcinoma: Furthermore, WAC-AS1’s functional role in breast invasive carcinoma was validated through multiple experiments, including qRT-PCR, lncRNA knockdown, CCK-8 assays, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining [77].